Later, we studied the possible clinical meaning of CDCA2 expression in glioma patients and found that high CDCA2 expression was related to several clinical parameters, such as chemo_status, relapses, and clinical stages, indicating that its overexpression may influence clinical progression of glioma. Here, CDCA2 is linked to central nervous system cancer.